Maca for Health & Longevity - Quick Reference Sheet

Maca for Health & Longevity

Created on 07/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Maca is a nutrient-dense Andean root taken mainly for low sexual desire, menopausal symptoms, energy, and fertility. It appears to raise sexual desire without changing measured sex hormones. The strongest evidence supports low libido in men and women; menopause support is mixed; other claims rest on small or laboratory studies. A low-risk, low-cost option. (Full Review)

Protocol

Dose
1.5–3 g/day
Powder or capsules; some protocols reach 3.5 g/day
Timing
Morning
Aligns with energizing effect; avoids sleep disruption
Ecotype
Match to goal
Black: energy/sperm; red: mood/menopause; yellow: all-purpose
Time to effect
Sexual desire
~6 weeks
Emerges around 6 weeks; builds through 12
Mood & energy
~6 weeks
Subjective gains over ~12 weeks of daily use
Full trial
8–12 weeks
Reassess desire, mood, and symptoms; stop if no effect

Benefits

Contraindications
  • Pregnancy and lactation
  • Hormone-sensitive cancers (e.g., ER-positive breast cancer)
  • Uncontrolled thyroid disease (high raw-maca intake)
Key Interactions
  • Antihypertensive drugs (e.g., lisinopril, amlodipine)
  • Thyroid hormone replacement (e.g., levothyroxine)
  • Blood-pressure-lowering supplements (e.g., garlic extract, CoQ10)
  • Stimulating botanicals (e.g., ginseng, guarana)

Risk & Side Effects

  • Low: Gastrointestinal discomfort; heavy-metal contamination
  • Speculative: Sleep disruption and overstimulation; goitrogenic and thyroid effects; effects in hormone-sensitive conditions

Monitoring

Marker Target Why
TSH 0.5–2.0 mIU/L Screens for goitrogenic effect, mainly with raw maca
Free T4 1.0–1.5 ng/dL Confirms thyroid status if TSH shifts
Total Testosterone (men) 500–900 ng/dL Baseline reference; maca is not expected to raise it
Estradiol Symptom- and context-dependent Baseline in menopausal users; maca does not act as a hormone

Cadence: Baseline before starting; at-risk users re-check thyroid at ~3 months, then every 6–12 months; others track symptoms

Qualitative Assessment

  • Sexual desire and sexual satisfaction
  • Energy and daytime fatigue
  • Mood and menopausal symptom burden
  • Sleep quality (watching for disruption from late dosing)
  • Exercise tolerance and recovery